Study of Anti-CD22 CAR-T Cells Treating Leukemia Children

Clinical trial NCT04340167 · COMPLETED

Trial details

NCT number: NCT04340167
Sponsor: Beijing Boren Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoblastic Leukemia

Start date: 2020-05-01
Primary completion: 2024-04-03
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.